153 related articles for article (PubMed ID: 26848589)
1. The Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental Mice.
Krupka M; Masek J; Barkocziova L; Turanek Knotigova P; Kulich P; Plockova J; Lukac R; Bartheldyova E; Koudelka S; Chaloupkova R; Sebela M; Zyka D; Droz L; Effenberg R; Ledvina M; Miller AD; Turanek J; Raska M
PLoS One; 2016; 11(2):e0148497. PubMed ID: 26848589
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP.
Křupka M; Mašek J; Bartheldyová E; Turánek Knötigová P; Plocková J; Korvasová Z; Škrabalová M; Koudelka Š; Kulich P; Zachová K; Czerneková L; Strouhal O; Horynová M; Šebela M; Miller AD; Ledvina M; Raška M; Turánek J
J Control Release; 2012 Jun; 160(2):374-81. PubMed ID: 22387453
[TBL] [Abstract][Full Text] [Related]
3. Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis.
Panelius J; Lahdenne P; Heikkilä T; Peltomaa M; Oksi J; Seppälä I
J Med Microbiol; 2002 Sep; 51(9):731-739. PubMed ID: 12358063
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.
Earnhart CG; Buckles EL; Dumler JS; Marconi RT
Infect Immun; 2005 Dec; 73(12):7869-77. PubMed ID: 16299277
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
Jacquet M; Durand J; Rais O; Voordouw MJ
Infect Genet Evol; 2015 Dec; 36():131-140. PubMed ID: 26384476
[TBL] [Abstract][Full Text] [Related]
6. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
Jobe DA; Lovrich SD; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
Edmondson DG; Prabhakaran S; Norris SJ; Ullmann AJ; Piesman J; Dolan M; Probst C; Radzimski C; Stöcker W; Komorowski L
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27733423
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.
Izac JR; Camire AC; Earnhart CG; Embers ME; Funk RA; Breitschwerdt EB; Marconi RT
Vaccine; 2019 Apr; 37(17):2401-2407. PubMed ID: 30922701
[TBL] [Abstract][Full Text] [Related]
9. Identification of B-cell epitopes of Borrelia burgdorferi outer surface protein C by screening a phage-displayed gene fragment library.
Pulzova L; Flachbartova Z; Bencurova E; Potocnakova L; Comor L; Schreterova E; Bhide M
Microbiol Immunol; 2016 Oct; 60(10):669-677. PubMed ID: 27619624
[TBL] [Abstract][Full Text] [Related]
10. Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi.
Baum E; Randall AZ; Zeller M; Barbour AG
PLoS One; 2013; 8(6):e67445. PubMed ID: 23826301
[TBL] [Abstract][Full Text] [Related]
11. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
Yang X; Li Y; Dunn JJ; Luft BJ
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
[TBL] [Abstract][Full Text] [Related]
13. N-terminal disulfide-bridging of Borrelia outer surface protein C increases its diagnostic and vaccine potentials.
Probst C; Ott A; Scheper T; Meyer W; Stöcker W; Komorowski L
Ticks Tick Borne Dis; 2012 Feb; 3(1):1-7. PubMed ID: 22309852
[TBL] [Abstract][Full Text] [Related]
14. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
Earnhart CG; Marconi RT
Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
[TBL] [Abstract][Full Text] [Related]
15. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
[TBL] [Abstract][Full Text] [Related]
16. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC.
Gilmore RD; Kappel KJ; Dolan MC; Burkot TR; Johnson BJ
Infect Immun; 1996 Jun; 64(6):2234-9. PubMed ID: 8675332
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
[TBL] [Abstract][Full Text] [Related]
18. A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses.
Scheiblhofer S; Weiss R; Dürnberger H; Mostböck S; Breitenbach M; Livey I; Thalhamer J
Microbes Infect; 2003 Sep; 5(11):939-46. PubMed ID: 12941385
[TBL] [Abstract][Full Text] [Related]
19. Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi.
Gilmore RD; Bacon RM; Carpio AM; Piesman J; Dolan MC; Mbow ML
J Med Microbiol; 2003 Jul; 52(Pt 7):551-556. PubMed ID: 12808075
[TBL] [Abstract][Full Text] [Related]
20. A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen.
Xiao S; Kumar M; Yang X; Akkoyunlu M; Collins PL; Samal SK; Pal U
Vaccine; 2011 Jul; 29(32):5294-303. PubMed ID: 21600949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
